Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
- Conditions
- Cardiac CT
- Interventions
- Device: ECG-Less Cardiac CT using SmartPhase
- Registration Number
- NCT05949138
- Lead Sponsor
- GE Healthcare
- Brief Summary
The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.
- Detailed Description
Data collected in this study will be used for technology development, scientific evaluation, marketing and education, and regulatory submissions for future products. This is a pre-market, prospective, open-label, non-randomized, single arm data collection clinical study conducted at one site in the United States of America.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
Subjects may be included in this study if they meet the following criteria:
- Who are 18 year of age or older;
- Able to sign and date the informed consent form; AND
- Who are scheduled for a clinical-indicated Cardiac CT exam that will include contrast administration.
Subjects may be excluded from participating in study if they meet any of the following criteria:
- Who are pregnant or lactating;
- Who were previously enrolled in this study;
- Anyone with known or suspected allergy to iodinated contrast agents;
- Anyone with known or suspected renal insufficiency as determined by site medical personnel;
- Who are scheduled for a CT cardiac calcium scoring test;
- Who are in need of urgent or emergent care;
- Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; AND
- Who are unwilling to have GEHC personnel present for the CT exam.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ECG-Less Cardiac CT ECG-Less Cardiac CT using SmartPhase Enrolled subjects will receive a clinically-indicated, diagnostic Cardiac CT with contrast. No ECG leads will be applied.
- Primary Outcome Measures
Name Time Method Data Collection Through study completion, an average of 6 months Number of Participants with raw investigational cardiac CT scan data
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
University of Washington
🇺🇸Seattle, Washington, United States
University of Chicago
🇺🇸Chicago, Illinois, United States